Across TCGA pan-cancer cohorts, RNU2-17P RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RNU2-17P’s most consistent transcriptional readouts.
The strongest signal is observed in kidney chromophobe (KICH), where RNU2-17P RNA is repressed in tumor relative to normal tissue. In most cancer types RNU2-17P is over-expressed in tumor, although a few such as KICH and BRCA show the opposite, repressed pattern.
KICH, BRCA, and PRAD are the cancer types where RNU2-17P tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU2-17P RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.